🇺🇸 FDA
Patent

US 11026969

High affinity T cell receptors and uses thereof

granted A61KA61K2300/00A61K35/12

Quick answer

US patent 11026969 (High affinity T cell receptors and uses thereof) held by Adaptive Biotechnologies Corporation expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Adaptive Biotechnologies Corporation
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2300/00, A61K35/12, A61K38/20, A61K40/11